We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+14.24%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.53B
AUM Growth
-$327M
Cap. Flow
-$1.11B
Cap. Flow %
-24.58%
Top 10 Hldgs %
41.66%
Holding
485
New
147
Increased
69
Reduced
132
Closed
95

Sector Composition

Rank Sector Weight
1 Financials 26.95%
2 Technology 10.95%
3 Healthcare 9.73%
4 Consumer Discretionary 8.75%
5 Real Estate 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBAY icon
76
eBay
EBAY
$48.9B
$13.1M 0.29%
250,000
-10,000
-4% -$423K
LVOX
77
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$13M 0.29%
1,238,895
-161,105
-12% -$1.62M
KCAC.U
78
DELISTED
Kensington Capital Acquisition Corp.Units, each consisting of one share of Class A common stock and
KCAC.U
$12.8M 0.28%
+1,278,139
New +$12.8M
XLF icon
79
State Street Financial Select Sector SPDR ETF
XLF
$58.4B
$12.7M 0.28%
+550,000
New +$12.5M
SCPE
80
DELISTED
SC Health Corporation
SCPE
$12.5M 0.28%
1,235,000
-65,000
-5% -$649K
RPLA
81
DELISTED
Replay Acquisition Corp. Ordinary Shares
RPLA
$12.1M 0.27%
1,187,500
-547,500
-32% -$5.48M
NFH
82
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$12M 0.27%
1,453,196
-26,894
-2% -$218K
GLIBA
83
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$12M 0.26%
+168,064
New +$10.8M
QNGY
84
DELISTED
Quanergy Systems, Inc.
QNGY
$11.8M 0.26%
+60,229
New +$11.7M
SCVX
85
DELISTED
SCVX Corp.
SCVX
$11.4M 0.25%
+1,140,000
New +$11.2M
JD icon
86
JD.com
JD
$44.3B
$11.3M 0.25%
187,050
+27,399
+17% +$1.39M
GTYH
87
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$11.1M 0.25%
2,674,581
+330,187
+14% +$1.29M
ARKO icon
88
ARKO Corp
ARKO
$818M
$11.1M 0.24%
1,068,358
-56,229
-5% -$564K
MNTS icon
89
Momentus
MNTS
$82.7M
$11.1M 0.24%
89
+5
+6% +$614K
PAE
90
DELISTED
PAE Incorporated Class A Common Stock
PAE
$10.9M 0.24%
1,140,000
-813,450
-42% -$7.24M
BMY.RT
91
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$10.7M 0.24%
2,978,600
-1,367,440
-31% -$4.93M
EGP icon
92
EastGroup Properties
EGP
$10.8B
$10.7M 0.24%
89,800
+85,253
+1,875% +$9.42M
UPH
93
DELISTED
UpHealth, Inc.
UPH
$10.4M 0.23%
102,230
-116,110
-53% -$11.6M
REXR icon
94
Rexford Industrial Realty
REXR
$8.14B
$10.2M 0.23%
+246,700
New +$9.91M
FSR
95
DELISTED
Fisker Inc.
FSR
$10.2M 0.22%
950,000
-346,259
-27% -$3.55M
GCMG icon
96
GCM Grosvenor
GCMG
$814M
$10.1M 0.22%
926,250
-48,750
-5% -$506K
RYAAY icon
97
Ryanair
RYAAY
$31.4B
$10M 0.22%
376,938
+34,658
+10% +$877K
HRTX icon
98
Heron Therapeutics
HRTX
$94.5M
$9.93M 0.22%
675,000
-725,000
-52% -$11.9M
DMS
99
DELISTED
Digital Media Solutions, Inc.
DMS
$9.88M 0.22%
63,333
-10,000
-14% -$1.55M
GNRS
100
DELISTED
Greenrose Acquisition Corp. Common Stock
GNRS
$9.79M 0.22%
+997,500
New +$9.73M

Similar funds

UBS O'Connor's Q2 2020 Portfolio in Review

As of Q2 2020, UBS O'Connor held 485 positions worth $4.53B, down 6.7% from $4.86B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

UBS O'Connor withdrew a net $1.11B in Q2 2020, closing 95 positions and reducing 132 holdings. Its most notable exit was Cypress Semiconductor, an estimated $394M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Claritev Corp worth $47.5M.

  • UBS O'Connor's largest Q2 2020 buy was Claritev Corp: 110,129 shares worth $47.5M.
  • UBS O'Connor added most to TD Ameritrade Holding Corp in Q2 2020, an estimated $214M increase.
  • UBS O'Connor's biggest Q2 2020 reduction was Tiffany & Co., cutting an estimated $121M.
  • UBS O'Connor fully exited Cypress Semiconductor in Q2 2020, selling an estimated $394M.
  • UBS O'Connor's ten largest holdings make up 42% of its $4.53B portfolio in Q2 2020.
  • UBS O'Connor opened 147 new positions and closed 95 in Q2 2020.
  • UBS O'Connor's portfolio value fell 6.7% quarter-over-quarter to $4.53B.

Based on UBS O'Connor's 13F filing for Q2 2020, filed 13 Aug 2020.